XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT

首页> 外文期刊>Bone marrow transplantation >XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT

【24h】

XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT

机译：XRCC1 399GG基因型预测，耐血管患者和ASCT治疗的抗性淋巴瘤患者的总体存活率明显更长

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2020年第4期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT [J] . Bone marrow transplantation . 2020,第4期

机译：XRCC1 399GG基因型预测，耐血管患者和ASCT治疗的抗性淋巴瘤患者的总体存活率明显更长
2. Fc gamma receptor 3a genotype in follicular lymphoma: the end of the story? Reply to “Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but n… | Haematologica [J] . Vít Procházka, Jana Gazdová, Tomá? Papajík Haematologica . 2012,第11期

机译：滤泡性淋巴瘤中的Fcγ受体3a基因型：故事的结局？回复“ Fcγ受体3a基因型可预测在SWOG试验中联合单克隆抗体加化学疗法治疗的滤泡性淋巴瘤患者的总体生存率，但无统计学意义……血液学
3. Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma [J] . MoskowitzC.H., MatasarM.J., ZelenetzA.D., Blood: The Journal of the American Society of Hematology . 2012,第7期

机译：使用二线，非交叉耐药性化疗方案对ASCT前FDG-PET成像进行归一化可改善霍奇金淋巴瘤患者的无事件生存率
4. Identification of Genes Important in Predicting the Overall Survival in Patients with Follicular Lymphoma [C] . Li Xiao, Kai Fu, Javeed Iqbal, International Conference on Data Mining . 2005

机译：鉴定卵腔淋巴瘤患者总生存的基因重要性
5. Estimation of G-CSF effectiveness in reducing neutropenia hospitalization among Non-Hodgkin's Lymphoma (NHL) patients treated with anthracycline-based chemotherapy. [D] . Pan, Xiaoyun. 2010

机译：估计G-CSF在以蒽环类为基础的化学疗法治疗的非霍奇金淋巴瘤（NHL）患者中减少中性粒细胞减少症住院的有效性。
6. Fc gamma receptor 3a genotype in follicular lymphoma: the end of the story? Reply to Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone. Haematologica. 2012;97(6):937-942 [O] . Vít Procházka, Jana Gazdová, Tomáš Papajík 2012

机译：滤泡性淋巴瘤中的Fcγ受体3a基因型：故事的结局？答复 Fcγ受体3a基因型预测在SWOG试验中接受联合单克隆抗体加化学疗法而非仅化学疗法治疗的滤泡性淋巴瘤患者的总体生存率。血液学。 2012; 97（6）：937-942
7. Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone [O] . Persky, Daniel O., Dornan, David, Goldman, Bryan H., 2012

机译：Fcγ受体3a基因型预测通过联合单克隆抗体加化学疗法而非单独化疗的SWOG试验治疗的滤泡性淋巴瘤患者的总体存活率

XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT

著录项

相似文献

相关主题

期刊订阅